Pilot Study of Nutrition in Maintenance Hemodialysis Patients
- Conditions
- End-Stage Renal DiseaseMealsHemodialysis
- Interventions
- Dietary Supplement: Meals
- Registration Number
- NCT02917278
- Lead Sponsor
- Purdue University
- Brief Summary
This pilot study aims to produce preliminary data on the safety of providing high-protein meals to patients during dialysis, and effects of this intervention on nutritional status and quality of life outcomes. This is a non-randomized, parallel arm study. Meals provided will follow recommended dietary guidelines for HD patients and will provide approximately 1/3 of daily recommended protein intake. Patients will be allocated to either the treatment or control group by HD shift schedule. 2 months of baseline data will be collected, followed by 9 weeks of meal intervention/control and data collection. The primary outcome will be frequency of hypotensive events during dialysis requiring intervention. Secondary outcomes will include highest and lowest systolic blood pressure during dialysis, blood biochemistries including measures of renal function, nutritional status, and electrolyte balance; dialysis compliance; fluid retention; sleep and other quality of life measures; and dietary intake data.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 19
- Men and women
- Any race
- Age 18 years or older
- Maintenance hemodialysis patients
• Patients with dysphagia that cannot be accommodated by texture modifications, or those exclusively NPO/requiring tube feeding or parenteral feeding
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Meals Meals High-protein renal-specific meals
- Primary Outcome Measures
Name Time Method Hypotensive Event Frequency 9 weeks frequency of hypotensive events that require intervention during dialysis
- Secondary Outcome Measures
Name Time Method Serum Sodium 9 weeks Hunger Rating 9 weeks Hunger rating on a visual analog scale of 0-10 cm. Higher values mean a better outcome.
Mean Arterial Pressure (mm Hg) 9 weeks Average Lowest Mean Arterial Pressure (mm Hg) over 25 dialysis sessions during the study.
Serum Albumin 9 weeks Blood Urea Nitrogen 9 weeks Serum Pre-albumin 9 weeks Dialysis Absences 9 weeks Absences out of 25 sessions
Serum Phosphate 9 weeks Vitality Score 9 weeks Vitality measured by SF-36 (Short Form 36 Health Survey) Questionnaire. Minimum-Maximum values 0-100, with higher scores meaning better outcomes.
Serum Creatinine 9 weeks Serum Chloride 9 weeks Serum CO2 9 weeks Sleep Problems Index 9 weeks Sleep Problems Index-II from the Medical Outcomes Study (MOS) Sleep Scale. Minimum-Maximum values 0-100, with higher scores meaning better outcomes.
Blood Glucose 9 weeks Serum Adjusted Calcium 9 weeks Interdialytic Weight Gain 9 weeks
Trial Locations
- Locations (1)
Purdue University
🇺🇸West Lafayette, Indiana, United States